Safety Data Sheet

Safety Data Sheet is supplied by DiaSorin S.p.A. under product code Calibrator 1, Calibrator 2, Specimen diluent, LIAISON Borrelia IgM II, LIAISON Control Borrelia IgM II, LIAISON Control Borrelia IgM Quant, LIAISON Control Borrelia IgM Liquor, LIAISON Borrelia IgM Quant, Conjugate, LIAISON HAV IgM, LIAISON Anti-HBs II, LIAISON Anti-HBs II Plus, LIAISON XL murex HCV Ab, LIAISON XL murex HBsAg Quant, LIAISON XL murex HIV Ab/Ag, LIAISON XL murex Control HIV Ab/Ag, LIAISON XL murex Chagas, LIAISON XL murex Control HIV Ab/Ag HT, LIAISON ANA Screen, LIAISON Control ANA Screen, LIAISON dsDNA, LIAISON Control dsDNA, LIAISON ENA Screen, LIAISON Control ENA Screen, LIAISON Cardiolipin IgG, LIAISON Cardiolipin IgM, LIAISON Rubella IgG, LIAISON Treponema Assay, LIAISON VZV IgG, LIAISON EBV IgM, LIAISON Control EBV IgM, LIAISON VCA IgG, LIAISON EBNA IgG, LIAISON EA IgG, LIAISON Toxo IgG II, LIAISON Toxo IgM, LIAISON Control Toxo IgM, LIAISON Toxo IgM II, LIAISON Control Toxo IgM, LIAISON Rubella IgG, LIAISON Control Rubella IgG, LIAISON Rubella IgM, LIAISON Control Rubella IgM, LIAISON CMV IgG, LIAISON Control CMV IgG, LIAISON CMV IgG II, LIAISON Control CMV IgG II, LIAISON CMV IgM, LIAISON Control CMV IgM, LIAISON CMV IgM II, LIAISON Control CMV IgM II, LIAISON CMV IgG Avidity II, LIAISON Control CMV IgG Avidity II, LIAISON Toxo IgG II, LIAISON Control Toxo IgG II, LIAISON XL Toxo IgG Avidity, LIAISON XL Control Toxo IgG Avidity, LIAISON HSV-1/2 IgG, LIAISON Control HSV-1/2 IgG, LIAISON HSV-1/2 IgM, LIAISON Control HSV-1/2 IgM, LIAISON Treponema Screen, LIAISON VZV IgG, LIAISON VZV IgM, LIAISON Borrelia IgG, LIAISON Control Borrelia IgG, LIAISON Control Borrelia IgG Liquor, LIAISON Measles IgG, LIAISON Mumps IgM, LIAISON Control Mumps IgM, LIAISON Mumps IgG. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 20 March 2015. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.